Navigation Links
Parkinson's Drugs Tied to Compulsive Behaviors
Date:5/10/2010

Impulse control disorders noted in patients include gambling and binge eating

MONDAY, May 10 (HealthDay News) -- Medicines used to treat Parkinson's disease may increase the risk of impulse control disorders, such as problem gambling, compulsive shopping and binge eating, researchers warn.

In a new study that included 3,090 patients being treated for Parkinson's at 46 movement disorder centers in the United States and Canada, the researchers found that 13.6 percent of the patients had impulse control disorders. These impulse disorders included gambling (5 percent), compulsive sexual behavior (3.5 percent), compulsive shopping (5.7 percent) and binge eating (4.3 percent), and nearly 4 percent of the patients had two or more of these disorders.

Impulse control disorders were more common among patients taking dopamine agonist medications (17.1 percent) than in those not taking the drugs (6.9 percent), the study authors found. Other factors associated with impulse control disorders were: use of levodopa (another treatment for Parkinson's); living in the United States; being younger or unmarried; smoking cigarettes; and having a family history of gambling problems.

"Dopamine agonist treatment in Parkinson's disease is associated with 2- to 3.5-fold increased odds of having an impulse control disorder," wrote Dr. Daniel Weintraub, of the University of Pennsylvania, Philadelphia, and Philadelphia VA Medical Center, and colleagues. "This association represents a drug class relationship across impulse control disorders. The association of other demographic and clinical variables with impulse control disorders suggests a complex relationship that requires additional investigation to optimize prevention and treatment strategies."

The researchers noted that dopamine agonists are increasingly being used to treat other conditions, such as fibromyalgia and restless legs syndrome.

"Larger . . . studies in these other populations are needed to examine the possible relationships between dopamine agonist treatment, other clinical features and impulse control disorders," the authors concluded.

The study is published in the May issue of the journal Archives of Neurology.

More information

The Parkinson's Disease Foundation has more about Parkinson's disease patients and impulse control problems.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, May 10, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Stomach Acid Drugs Come with Dangers, Studies Show
2. Anemia Drugs Hold Dangers for Kidney Patients
3. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
4. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
5. OTC Drugs May Work Differently in Obese Kids
6. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
7. BATTLE links potential biomarkers to drugs for lung cancer
8. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
9. Cholesterol Drugs May Slow MS
10. Real Men Don't Take Erectile Dysfunction Drugs Without a Prescription
11. Poisoning by prescription drugs on the rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published by ... Schanssema describes the tragedies he saw, as well as his struggles with grief and ... unsure of the career path he wanted to take, found fulfillment in a career ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO ... year. Dyer started as the Chairman of the Management Committee when IFN was ... corporation including the recruitment of investor/owners and development of the business plan. He ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Physician General Dr. Rachel Levine and ... Smith commended South Central EMS today for their ... a life-saving overdose reversal drug. The recognition event also ... overdose survivor who was saved due to the administration ... part of fighting the opioid epidemic is making sure ...
(Date:2/24/2017)... 2017 Report analyzes the worldwide markets for Endodontic ... for the US, Canada , ... Asia-Pacific , Latin America , and ... the period 2015 through 2022. Also, a six-year historic analysis ... derived from primary and secondary research. Company profiles are primarily ...
(Date:2/24/2017)... Feb. 23, 2017 Non-alcoholic steatohepataitis ... the various drugs being developed for the ... the drugs that are in various phases ... pipeline focuses on novel pharmacologic drugs & ... cell therapies, recombinant proteins and RNA-based therapeutics, ...
Breaking Medicine Technology: